Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28783166
Publication Date : //

Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.


Dysregulation of microRNAs (miRNAs) plays an important role in the pathogenesis of chronic lymphocytic leukemia (CLL). The Eμ-TCL1 transgenic mouse develops a form of leukemia that is similar to the aggressive type of human B-CLL, and this valuable model has been widely used for testing novel therapeutic approaches. Here, we adopted this model to investigate the potential effects of miR-26a, miR-130an and antimiR-155 in CLL therapy. Improved delivery of miRNA molecules into CLL cells was obtained by developing a novel system based on lipid nanoparticles conjugated with an anti-CD38 monoclonal antibody. This methodology has proven to be highly effective in delivering miRNA molecules into leukemic cells. Short- and long-term experiments showed that miR-26a, miR-130a and anti-miR-155 increased apoptosis after in vitro and in vivo treatment. Of this miRNA panel, miR-26a was the most effective in reducing leukemic cell expansion. Following long-term treatment, apoptosis was readily detectable by analyzing cleavage of PARP and caspase-7. These effects could be directly attributed to miR-26a, as confirmed by significant downregulation of its proven targets, namely cyclin-dependent kinase 6 and Mcl1. The results of this study are relevant to two distinct areas. The first is related to the design of a technical strategy and to the selection of CD38 as a molecular target on CLL cells, both consenting efficient and specific intracellular transfer of miRNA. The original scientific finding inferred from the above approach is that miR-26a can elicit in vivo anti-leukemic activities mediated by increased apoptosis.

Authors : D'Abundo L , Callegari E , Bresin A , Chillemi A , Elamin B K , Guerriero P , Huang X , Saccenti E , Hussein E M A A , Casciano F , Secchiero P , Zauli G , Calin G A , Russo G , Lee L J , Croce C M , Marcucci G , Sabbioni S , Malavasi F , Negrini M ,

Related products :

Catalog number Product name Quantity
T18-011-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-010-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
E7671h Human Chronic Lymphocytic Leukemia Up Regulated Pr 96T
T18-009-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
T18-010-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
T18-011-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) tissue 0.1 mg
CLMN CLLU1 Gene chronic lymphocytic leukemia up-regulated 1
CSB-EL005562HU Human Chronic lymphocytic leukemia up-regulated protein 1(CLLU1) ELISA kit 96T
CLN3 CLLU1OS Gene chronic lymphocytic leukemia up-regulated 1 opposite strand
EIAAB07928 Chronic lymphocytic leukemia up-regulated protein 1,CLLU1,Homo sapiens,Human
CSB-EL005562HU Human Chronic lymphocytic leukemia up-regulated protein 1(CLLU1) ELISA kit SpeciesHuman 96T
CLLU1_HUMAN ELISA Kit FOR Chronic lymphocytic leukemia up-regulated protein 1; organism: Human; gene name: CLLU1 96T
G5250 Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein (CLLU1OS), Human, ELISA Kit 96T
CSB-EL005562HU Human chronic lymphocytic leukemia up-regulated 1 (CLLU1) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL005563HU Human Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein(CLLU1OS) ELISA kit 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur